PERTUZUMAB Pharmacologic Class Indexing
- Class set ID
- 2c73139d-d90c-43e5-826e-03b8b41acea0
- Version
- 3
- Effective date
- 20180813
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| These highlights do not include all the information needed to use PHESGO safely and effectively. See full prescribing information for PHESGO. PHESGO ® (pertuzumab, trastuzumab, and hyaluronidase-zzxf) injection, for subcutaneous use Initial U.S. Approval: 2020 | Genentech, Inc. | Roche Diagnostics GmbH | F. Hoffmann-La Roche AG | Genentech, Inc. (Oceanside) | Roche Singapore Technical Operations Pte. Ltd | 20260521 | 17 |
| These highlights do not include all the information needed to use PERJETA safely and effectively. See full prescribing information for PERJETA. PERJETA ® (pertuzumab) injection, for intravenous use Initial U.S. Approval: 2012 | Genentech, Inc. | Roche Diagnostics GmbH | F. Hoffmann-La Roche AG | Roche Diagnostics | Genentech, Inc. (Hillsboro) | Genentech, Inc. (Oceanside) | 20260430 | 27 |